COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF SYMPTOMATIC CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN PORTUGAL

被引：0
|
作者：
Alarcao, J. [1 ]
Ascencao, R. [1 ]
Costa, J. [2 ]
Gouveia, M. [3 ]
Borges, M. [1 ]
机构：
[1] Univ Lisbon, Fac Med, Ctr Estudos Med Baseada Evidencia, Lisbon, Portugal
[2] Univ Lisbon, Fac Med, Lab Farmacol Clin & Terapeut, Lisbon, Portugal
[3] Catolica Lisbon Sch Business & Econ, Lisbon, Portugal
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.618
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV71
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of sacubitril/valsartan for the treatment of patients with heart failure with reduced ejection fraction in Portugal
    Borges, Margarida
    Afonso-Silva, Marta
    Laires, Pedro A.
    Gouveia, Miguel
    Alarcao, Joana
    Ascencao, Raquel
    Costa, Joao
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (02) : 199 - 205
  • [2] The cost-effectiveness of sacubitril/valsartan in chronic heart failure with reduced ejection fraction
    Mcmurray, J. J. V.
    Cowie, M. R.
    Briggs, A.
    Taylor, M.
    Hancock, E.
    Trueman, D. David
    Haroun, R.
    Deschaseaux, C.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 276 - 276
  • [3] REAL-WORLD COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN SYMPTOMATIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN PORTUGAL
    Afonso-Silva, M.
    Laires, P. A.
    [J]. VALUE IN HEALTH, 2019, 22 : S545 - S545
  • [4] Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    McMurray, John J. V.
    Trueman, David
    Hancock, Elizabeth
    Cowie, Martin R.
    Briggs, Andrew
    Taylor, Matthew
    Mumby-Croft, Juliet
    Woodcock, Fionn
    Lacey, Michael
    Haroun, Rola
    Deschaseaux, Celine
    [J]. HEART, 2018, 104 (12) : 1006 - 1013
  • [5] THE COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN TURKEY
    Sarioz, F.
    Ozdemir, O.
    Direk, S.
    Caglar, P.
    Ar, I
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A616 - A616
  • [6] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION IN SINGAPORE
    Declan, L.
    Tang, Z. X.
    Ng, C.
    Tan, J.
    Trueman, D.
    Woodcock, F.
    Cristino, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S106 - S106
  • [7] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN HEART FAILURE WITH REDUCED EJECTION FRACTION IN SWEDEN
    Costa-Scharplatz, M.
    Lang, A.
    McMurray, J. J.
    Woodcock, F.
    Haroun, R.
    Johansson, D.
    Lund, L. H.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A650 - A651
  • [8] COST-EFFECTIVENESS ANALYSIS OF SACUBITRIL/VALSARTAN IN CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN SPAIN
    Lacasa, C.
    Obradors, M.
    Figueras, M.
    Perez-Alcantara, F.
    Brosa, M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A650 - A650
  • [9] Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction
    Zanfina, Ademi
    Alena, Pfeil Ma
    Elizabeth, Hancock
    David, Trueman
    Rola, Haroun
    Celine, Deschaseaux
    Matthias, Schwenkglenks
    [J]. SWISS MEDICAL WEEKLY, 2017, 147
  • [10] THE COST EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN KOREA
    Lee, J.
    Ko, S.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A617 - A618
12345